
The aim of this study was to determine zzso of breakthrough pain medication among a zzso group of zzso zzso The subjects were recruited from patients attending the zzso zzso department and zzso day zzso The protocol involved completion of a zzso zzso the information collected included demographic information zzso age, zzso cancer diagnosis, background cancer pain management, breakthrough pain characteristics zzso frequency, zzso zzso and breakthrough cancer pain zzso One hundred zzso patients participated in the zzso zzso patients were experiencing breakthrough pain, although only 81 patients had been prescribed a strong zzso as breakthrough zzso Three patients had never taken the breakthrough medication, because of concerns about zzso concerns about zzso and zzso about the existence of breakthrough zzso Of the remaining patients, 15 used the zzso every time they experienced breakthrough pain, whereas 63 used the zzso only some of the times they experienced breakthrough zzso The patients' impetus for taking breakthrough medication varied zzso onset of pain, duration of pain, intensity of zzso and the patients' reasons for not always taking breakthrough medication also varied zzso lack of intensity of pain, side effects of breakthrough medication, concerns about side effects of breakthrough zzso This study confirms that most patients do not take breakthrough medication every time they experience breakthrough zzso It also identified educational needs around the management of breakthrough pain for both patients and health care zzso 

